Major Bleed Risk Falls With Bivalirudin vs Heparin en Route to PCI for STEMI

Major Bleed Risk Falls with Bivalirudin vs Heparin en Route to PCI for STEMI

Filed under: drug in san francisco

SAN FRANCISCO, CA (updated)— The 30-day risk of death or major bleeding fell significantly in ST-elevation MI (STEMI) patients treated with bivalirudin (Angiomax, the Medicines Company) compared with heparin-based management, both initiated prior to …
Read more on Medscape

 

BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD

Filed under: drug treatment programs in san francisco

RESEARCH TRIANGLE PARK, N.C. and SOUTH SAN FRANCISCO, Calif., Oct. 30, 2013 /PRNewswire via COMTEX/ — GlaxoSmithKline plc (lse/nyse:GSK) and Theravance, Inc. (NASDAQ:THRX) today announced that BREO ELLIPTA, a once-daily prescription medicine for …
Read more on MarketWatch

 

Editorial: Herrera for city attorney

Filed under: drug treatment programs in san francisco

With regard to City College of San Francisco, Herrera's office recently filed a lawsuit against the Accrediting Commission for Community and Junior Colleges, alleging that the private agency unlawfully allowed its advocacy and political bias to …
Read more on Bay Area Reporter

 

Five Prime Therapeutics Inc (FPRX): Five Prime: A Growing Oncology And

Filed under: drug treatment programs in san francisco

Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic – human insulin – 25 years ago. Protein therapeutics …
Read more on Seeking Alpha

 


Tags: , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *